Endothelium and Oxidative Stress: The Pandora's Box of Cerebral (and Non-Only) Small Vessel Disease?

M Maccarrone1, L Ulivi1, N Giannini1

  • 1Department of Experimental and Clinical Medicine, Neurological Institute, University of Pisa, Via Rome 67, 56100 Pisa. Italy.

Insights

Cerebral small vessel disease (cSVD) is linked to aging and vascular risks. This review explores endothelial dysfunction and oxidative stress as key factors, suggesting new ways to assess and manage this condition.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Geriatrics

Background:

  • Cerebral small vessel disease (cSVD) is a common finding in older adults, leading to disability and reduced quality of life.
  • cSVD is associated with age, hypertension, diabetes, dyslipoproteinemia, smoking, low vitamin B12, and hyperhomocysteinemia.
  • The precise etiopathogenetic mechanisms underlying cSVD remain unclear despite epidemiological associations.

Purpose of the Study:

  • To review the potential role of endothelial dysfunction and oxidative stress in the pathogenic cascade of cSVD.
  • To highlight the importance of quantifying endothelial and oxidative stress burden in determining vascular risk.
  • To explore how understanding these mechanisms can help slow cSVD progression and prevent disability.

Main Methods:

  • Literature review focusing on endothelial dysfunction and oxidative stress in cSVD.
  • Analysis of epidemiological associations and proposed pathogenic pathways.
  • Discussion of potential clinical applications for risk assessment and management.

Main Results:

  • Endothelial dysfunction and oxidative stress are proposed as central pathways in cSVD pathogenesis.
  • Quantifying "endotheliopathic and oxidative load" may improve vascular risk assessment.
  • These pathways offer potential targets for interventions to slow disease progression.

Conclusions:

  • Endothelial dysfunction and oxidative stress are critical contributors to cSVD.
  • Assessing the "endotheliopathic and oxidative load" could refine clinical risk stratification.
  • Targeting these mechanisms may offer a strategy to prevent disability from microvascular damage.